Annual CAPEX
$1.05 M
-$2.15 M-67.12%
December 31, 2022
Summary
- As of February 10, 2025, AMAM annual capital expenditures is $1.05 million, with the most recent change of -$2.15 million (-67.12%) on December 31, 2022.
- During the last 3 years, AMAM annual CAPEX has risen by +$1.01 million (+2095.83%).
Performance
AMAM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
$298.00 K
-$485.00 K-61.94%
September 1, 2023
Summary
- As of February 10, 2025, AMAM quarterly capital expenditures is $298.00 thousand, with the most recent change of -$485.00 thousand (-61.94%) on September 1, 2023.
- Over the past year, AMAM quarterly CAPEX has increased by +$194.00 thousand (+186.54%).
Performance
AMAM Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
$1.13 M
+$194.00 K+20.77%
September 1, 2023
Summary
- As of February 10, 2025, AMAM TTM capital expenditures is $1.13 million, with the most recent change of +$194.00 thousand (+20.77%) on September 1, 2023.
- Over the past year, AMAM TTM CAPEX has increased by +$121.00 thousand (+12.02%).
Performance
AMAM TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
AMAM CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -67.1% | +186.5% | +12.0% |
3 y3 years | +2095.8% | - | - |
5 y5 years | +2095.8% | - | - |
AMAM CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -67.1% | at low | -61.9% | -84.2% | at high | -31.4% |
5 y | 5-year | -67.1% | -95.4% | -61.9% | -84.2% | at high | -31.4% |
alltime | all time | -67.1% | -95.4% | -61.9% | -84.2% | at high | -31.4% |
Ambrx Biopharma CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2023 | - | $298.00 K(-61.9%) | $1.13 M(+20.8%) |
Jun 2023 | - | $783.00 K(+1566.0%) | $934.00 K(-11.4%) |
Dec 2022 | $1.05 M | $47.00 K(-54.8%) | $1.05 M(+4.7%) |
Sep 2022 | - | $104.00 K(-19.4%) | $1.01 M(+11.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2022 | - | $129.00 K(-83.3%) | $903.00 K(+16.7%) |
Mar 2022 | - | $774.00 K | $774.00 K |
Dec 2021 | $3.21 M(+1172.2%) | - | - |
Dec 2020 | $252.00 K(+425.0%) | - | - |
Dec 2019 | $48.00 K | - | - |
FAQ
- What is Ambrx Biopharma annual capital expenditures?
- What is the all time high annual CAPEX for Ambrx Biopharma?
- What is Ambrx Biopharma annual CAPEX year-on-year change?
- What is Ambrx Biopharma quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Ambrx Biopharma?
- What is Ambrx Biopharma quarterly CAPEX year-on-year change?
- What is Ambrx Biopharma TTM capital expenditures?
- What is the all time high TTM CAPEX for Ambrx Biopharma?
- What is Ambrx Biopharma TTM CAPEX year-on-year change?
What is Ambrx Biopharma annual capital expenditures?
The current annual CAPEX of AMAM is $1.05 M
What is the all time high annual CAPEX for Ambrx Biopharma?
Ambrx Biopharma all-time high annual capital expenditures is $3.21 M
What is Ambrx Biopharma annual CAPEX year-on-year change?
Over the past year, AMAM annual capital expenditures has changed by -$2.15 M (-67.12%)
What is Ambrx Biopharma quarterly capital expenditures?
The current quarterly CAPEX of AMAM is $298.00 K
What is the all time high quarterly CAPEX for Ambrx Biopharma?
Ambrx Biopharma all-time high quarterly capital expenditures is $783.00 K
What is Ambrx Biopharma quarterly CAPEX year-on-year change?
Over the past year, AMAM quarterly capital expenditures has changed by +$194.00 K (+186.54%)
What is Ambrx Biopharma TTM capital expenditures?
The current TTM CAPEX of AMAM is $1.13 M
What is the all time high TTM CAPEX for Ambrx Biopharma?
Ambrx Biopharma all-time high TTM capital expenditures is $1.13 M
What is Ambrx Biopharma TTM CAPEX year-on-year change?
Over the past year, AMAM TTM capital expenditures has changed by +$121.00 K (+12.02%)